(Total Views: 614)
Posted On: 12/13/2020 11:44:31 AM
Post# of 153940
Ohm and I are probably limiting the valuations based on how much PRO140/Lernlimab/Vyrologix is available to be sold near term.
More accurate (what an understatement) valuations can be developed when CytoDyn publishes their quarterly earnings statement after a solid quarter of sales.
More accurate (what an understatement) valuations can be developed when CytoDyn publishes their quarterly earnings statement after a solid quarter of sales.
(0)
(0)
